PuSH - Publication Server of Helmholtz Zentrum München

Warncke, K. ; Weiss, A. ; Achenbach, P. ; von dem Berge, T.* ; Berner, R.* ; Casteels, K.* ; Groele, L.* ; Hatzikotoulas, K. ; Hommel, A. ; Kordonouri, O.* ; Elding Larsson, H.* ; Lundgren, M.* ; Marcus, B.A. ; Snape, M.D.* ; Szypowska, A.* ; Todd, J.A.* ; Bonifacio, E. ; Ziegler, A.-G.

Elevations in blood glucose before and after the appearance of islet autoantibodies in children.

J. Clin. Invest. 132:e162123 (2022)
Publ. Version/Full Text Research data DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
The etiology of type 1 diabetes has polygenic and environmental determinants that lead to autoimmune responses against pancreatic β cells and promote β cell death. The autoimmunity is considered silent without metabolic consequences until late preclinical stages,and it remains unknown how early in the disease process the pancreatic β cell is compromised. To address this, we investigated preprandial nonfasting and postprandial blood glucose concentrations and islet autoantibody development in 1,050 children with high genetic risk of type 1 diabetes. Pre- and postprandial blood glucose decreased between 4 and 18 months of age and gradually increased until the final measurements at 3.6 years of age. Determinants of blood glucose trajectories in the first year of life included sex, body mass index, glucose-related genetic risk scores, and the type 1 diabetes-susceptible INS gene. Children who developed islet autoantibodies had early elevations in blood glucose concentrations. A sharp and sustained rise in postprandial blood glucose was observed at around 2 months prior to autoantibody seroconversion, with further increases in postprandial and, subsequently, preprandial values after seroconversion. These findings show heterogeneity in blood glucose control in infancy and early childhood and suggest that islet autoimmunity is concurrent or subsequent to insults on the pancreatic islets.
Impact Factor
Scopus SNIP
Altmetric
19.456
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Diabetes ; Immunology ; Insulin
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 0021-9738
e-ISSN 1558-8238
Quellenangaben Volume: 132, Issue: 20, Pages: , Article Number: e162123 Supplement: ,
Publisher American Society of Clinical Investigation
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research (IDF)
Institute of Translational Genomics (ITG)
Institute of Pancreatic Islet Research (IPI)
POF-Topic(s) 30201 - Metabolic Health
30205 - Bioengineering and Digital Health
90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
Genetics and Epidemiology
PSP Element(s) G-502100-001
G-508800-010
G-506700-001
G-502600-006
Scopus ID 85139887851
PubMed ID 36250461
Erfassungsdatum 2022-10-24